Search

SCI health care provider attitudes about pressure ulcer management.

Marylou Guihan, Barry Goldstein, Bridget M Smith, Alan Schwartz, Larry M Manheim

School-Aged Outcomes After Neonatal Arterial Ischemic Stroke

Theresa Czech, Andrea C Pardo

Scholarly Products for the Global Health Trainee: a Guide for Educators.

Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.

Paula R Clemens, Vamshi K Rao, Anne M Connolly, Amy D Harper, Jean K Mah, Edward C Smith, Craig M McDonald, Craig M Zaidman, Lauren P Morgenroth, Hironori Osaki, Youhei Satou, Taishi Yamashita, Eric P Hoffman

Safety of Ventricular Reservoir Sampling in Pediatric Posthemorrhagic Hydrocephalus Patients: Institutional Experience and Review of the Literature.

Daphne Li, Kathy Romanski, Maureen Kilgallon, Stacy Speck, Robin Bowman, Arthur DiPatri, Tord Alden, Tadanori Tomita, Sandi Lam, Amanda M Saratsis

Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria

Bernd Hoppe, Annelize Koch, Pierre Cochat, Sander F Garrelfs, Michelle A Baum, Jaap W Groothoff, Graham Lipkin, Martin Coenen, Gesa Schalk, Aniruddha Amrite, David McDougall, Kelly Barrios, Craig B Langman

Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy

Julie Wang, Stacie M Jones, Jacqueline A Pongracic, Ying Song, Nan Yang, Scott H Sicherer, Melanie M Makhija, Rachel G Robison, Erin Moshier, James Godbold, Hugh A Sampson, Xiu-Min Li

Safety of Sports for Young Patients With Implantable Cardioverter-Defibrillators

Elizabeth Vickers Saarel, Ian Law, Charles I Berul, Michael J Ackerman, Ronald J Kanter, Shubhayan Sanatani, Mitchell I Cohen, Stuart Berger, Peter S Fischbach, David A Burton, James Dziura, Cynthia Brandt, Laura Simone, Fangyong Li, Brian Olshansky, David S Cannom, Rachel J Lampert

Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria.

Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.

Inge M G J Bronckers, Marieke M B Seyger, Dennis P West, Irene Lara-Corrales, Megha Tollefson, Wynnis L Tom, Marcia Hogeling, Leah Belazarian, Claus Zachariae, Emmanuel Mahé, Elaine Siegfried, Sandra Philipp, Zsuzsanna Szalai, Ruth Ann Vleugels, Kristen Holland, Ruth Murphy, Eulalia Baselga, Kelly Cordoro, Jo Lambert, Alex Alexopoulos, Ulrich Mrowietz, Wietske Kievit, Amy S Paller

Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis.

Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies.